The main issue with the ongoing coronavirus outbreak is that even global health experts remain unclear on how things are going to play out in terms of disease spread and severity. Given all the unknowns over whether the now officially named SARS-CoV-2 virus will go fully global or fizzle out, pharma companies are also having a hard time predicting the precise future impact.
Specific comments on how the outbreak, originating from the Chinese city of Wuhan, are affecting and may hit business were...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
